Krishna K. Kolluri

TRAIL delivery by MSC‐derived extracellular vesicles is an effective anticancer therapy

Zhengqiang Yuan, Krishna K. Kolluri, Kate H.C. Gowers et al. · Journal of Extracellular Vesicles · 2017 · 179 citations · Full text

Cell-based Drug Delivery, Extracellular Vesicles, Nanomedicine +13

Mesenchymal stromal cell delivery of full-length tumor necrosis factor–related apoptosis-inducing ligand is superior to soluble type for cancer therapy

Zhengqiang Yuan, Krishna K. Kolluri, Elizabeth K. Sage et al. · Cytotherapy · 2015 · 68 citations · Full text

Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma

Elizabeth K. Sage, Krishna K. Kolluri, Katrina McNulty et al. · Thorax · 2014 · 65 citations · Full text

Tumour Growth, Adult Stem Cell, Immunology +20

Lung delivery of MSCs expressing anti-cancer protein TRAIL visualised with 89Zr-oxine PET-CT

P. Stephen Patrick, Krishna K. Kolluri, May Zaw Thin et al. · Stem Cell Research & Therapy · 2020 · 51 citations · Full text

CADM1 inhibits squamous cell carcinoma progression by reducing STAT3 activity

Sabari Vallath, Elizabeth K. Sage, Krishna K. Kolluri et al. · Scientific Reports · 2016 · 42 citations · Full text